Key result
Overexpression of miR-29b-3p significantly reduced hypoxia-induced apoptosis in AC16 cardiomyocytes from 57.58% to 21.83% by targeting TRAF5.
Why the study?
MicroRNAs are pivotal regulators in hypoxia-induced cardiomyocyte injury, prompting evaluation of the effects of miR-29b-3p on hypoxic cardiomyocytes.
Does miR-29b-3p overexpression prevent hypoxia-induced apoptosis and improve cell viability in human AC16 cardiomyocytes?
Does miR-29b-3p overexpression prevent hypoxia-induced apoptosis and improve cell viability in human AC16 cardiomyocytes?
Absolute Event Rate: 21.83% vs 57.58%
p-value: p=<0.001
Upregulation of miR-29b-3p protects cardiomyocytes against hypoxia-induced injury by downregulating TRAF5, suggesting a potential therapeutic target for acute myocardial infarction.
Hypothesis-generating for miR-29b-3p in hypoxic cardiomyocytes; leaves open translation to human myocardial infarction.
BACKGROUND: MicroRNAs (miRNAs) are pivotal regulators in regulating hypoxia-induced cardiomyocyte injury. This study was designed to evaluate the effects of miR-29b-3p on hypoxic cardiomyocytes. METHODS: Human AC16 cells were cultured under normoxic or hypoxic conditions. Hypoxic injury was confirmed based on alterations in cell viability using CCK-8 assay and apoptosis using flow cytometry and Hoechst staining. Bioinformatics analyses and the dual-luciferase reporter assay were performed to predict and validate the target gene of miR-29b-3p. RESULTS: We found that hypoxia suppressed cell viability and promoted apoptosis. TNF receptor-associated factor 5 (TRAF5) was a potential target gene of miR-29b-3p. Our in vitro experiments revealed that miR-29b-3p overexpression or TRAF6 knockdown significantly protected cardiomyocytes against hypoxia-induced injury. Moreover, knockdown of TRAF5 knockdown potentiated the protective effects of miR-29b-3p against hypoxia-induced cell injury. CONCLUSION: These findings suggest that upregulation of miR-29b-3p could protect cardiomyocytes against hypoxia-induced injury through downregulation of TRAF5. Targeting TRAF5 with miR-29b-3p might be a potential therapeutic method for AMI.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2019) studied Hypoxia-induced cardiomyocyte injury (Acute Myocardial Infarction model). miR-29b-3p overexpression vs. miR-NC (negative control) was evaluated on Percentage of apoptotic cells (p=<0.001). Overexpression of miR-29b-3p significantly reduced hypoxia-induced apoptosis in AC16 cardiomyocytes from 57.58% to 21.83% by targeting TRAF5.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: